Webinar Date/Time: Tuesday, March 21st, 2023 at 9am EDT | 6am PDT | 1pm GMT | 2pm CET
Today, clinical trial sites and sponsors need informed consent solutions that are flexible enough to be delivered in hybrid and decentralized trials. In this webinar, we will discuss how to navigate this complex environment with a flexible, feature-rich eConsent platform can facilitate remote consent from multiple signers in different locations and help sites monitor and track the consent process in real-time throughout the study.
Today, clinical trial sponsors and sites need informed consent solutions that are flexible enough to meet the demands of hybrid and decentralized models while ensuring patient-centricity and regulatory compliance. That’s why a feature-rich, compliant electronic consent (eConsent) platform that can facilitate a simplified traceable remote consent in diverse locations is critical to delivering modern clinical trials worldwide.
In this webinar, IQVIA Complete Consent leaders will share how eConsent can deliver an engaging informed consent experience while supporting diverse study protocols. We will discuss how to collect remote consent from multiple signers in different locations, while effortlessly monitoring and tracking the process throughout the trial lifecycle.
Three key take-aways:
Director of Operational Effectiveness, Patient Consent
David Lake is an operations leader focused on the deployment, training, and implementation of eConsent. With over 16 years of technology, software-as-service (SaaS), and operations experience, David has spent the last six years developing and delivering electronic informed consent platforms – supporting everything from content creation, product development, project management, and process improvement. He is extremely passionate about the benefits of electronic consent, especially the transparency and patient centricity it provides. He is a subject matter expert for IQVIA Complete Consent and enjoys helping customers get the most value out of eConsent for their trials and the patients they serve.
Associate Director of Product, Patient Consent
With over 25 years of technology expertise, Dana Wershiner is passionate about designing and developing products that truly meets users’ needs while delivering innovation and strategic value. In her current role, Dana leads the IQVIA Complete Consent product team in scoping and documenting new product features, collaborating with engineers, delivery integration, and project management teams to deliver a feature-rich consent solution to customers.